Modern Treatment Regimens for Chronic Obstructive Pulmonary Disease
DOI:
https://doi.org/10.51699/ijhsms.v1i6.691Keywords:
chronic obstructive pulmonary disease, principles and schemes of treatmentAbstract
According to modern concepts, chronic obstructive pulmonary disease (COPD) is "a disease characterized by airflow limitation that is not fully reversible; airflow limitation is progressive and associated with a pathological inflammatory response of the lungs to the action of inhaled pathogenic particles or gases. The primary target of COPD is the respiratory organs. The main clinical manifestations of COPD are cough, sputum production and progressive dyspnea. External respiratory function in COPD is characterized by the emergence of slowly increasing airflow restrictions with progressive reduction of forced expiratory volume per second (FEF1) and Hensler index (FEF1/FEL) due to increased resistance in the airways with subsequent deterioration of gas exchange in the lungs. Complications of COPD are known: pulmonary hyperinflation (pulmonary emphysema), chronic respiratory failure, secondary pre-capillary pulmonary hypertension and chronic pulmonary heart disease, which should be considered as natural manifestations of the natural course of COPD.
Downloads
References
Diaz-Guzman E., Mannino D.M. Epidemiology and prevalence of chronicobstructive pulmonary disease. Clin Chest. Med. 2014;35(1):7–16. Doi: 10.1016/j.ccm.2013.10.002.
Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease (Update 2019). Available from: http://www.goldcopd.org.
O’Donnell D.E., Parker C.M. COPD exacerbations: Pathophysiol Thorax. 2006;61:354–61.
Donaldson G.C., Seemungal T.A.R., Bhowmik A.,Wedzicha J.A. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax. 2002;57:847–52.
Marchetti N., Criner G.J., Albert R.K. Preventing acute exacerbations and hospital admissions in COPD. Chest. 2013;143(5):1444–54. Doi: 10.1378/chest.12-1801.
Саидова М. М. ОЦЕНКА ПАРАМЕТРОВ ТОЛЩИНЫ ИНТИМА-МЕДИА СОННЫХ АРТЕРИЙ КАК РАННЕГО ПРЕДИКТОРА РАЗВИТИЯ АТЕРОСКЛЕРОЗА У БОЛЬНЫХ РЕВМАТОИДНЫМ АРТРИТОМ //Журнал кардиореспираторных исследований. – 2022. – Т. 3. – №. 1.
Саидова М.М., Камилова У.К. СЕРДЕЧНО-СОСУДИСТЫЙ РИСК ПО ШКАЛЕ MSCORE У БОЛЬНЫХ РЕВМАТОИДНЫМ АРТРИТОМ // ЕКЖ. 2019. №S1. URL: https://cyberleninka.ru/article/n/serdechno-sosudistyy-risk-po-shkale-mscore-u-bolnyh-revmatoidnym-artritom (дата обращения: 25.11.2022).
Саидова М. М., Камилова У. К. Анализ встречаемости кардиоваскулярной коморбидности у больных ревматоидным артритом //Артериальная гипертония 2017 как междисциплинарная проблема. – 2017. – С. 41-42.
Саидова М. М., Хамроева Ю. С. СЕРДЕЧНО-СОСУДИСТЫЙ РИСК У БОЛЬНЫХ СИСТЕМНОЙ СКЛЕРОДЕРМИЕЙ //Новый день в медицине. – 2021. – №. 1. – С. 265-269.
Саидова М. М., Хамроева Ю. С. CARDIOVASCULAR RISK IN PATIENTS WITH SYSTEMIC SCLERODERMA //Новый день в медицине. – 2020. – №. 1. – С. 367-370.
